Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-23-033401

Options or other derivatives

  • CHIEF COMMERCIAL OFFICER acquired 48,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wiley Matthew T. · CHIEF COMMERCIAL OFFICER

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-03-15 Grant or award : show line 1 in the form Restricted Stock Units +12,000 12,000 D
2023-03-15 Grant or award : show line 2 in the form Stock Option (Right to Buy) +36,000 36,000 D
Loading xslF345X03/tm239796-2_4seq1.xml…